Aflac Incorporated (NYSE:AFL) Stock Holdings Increased by Kingswood Wealth Advisors LLC

Kingswood Wealth Advisors LLC grew its position in shares of Aflac Incorporated (NYSE:AFL) by 161.7% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 6,806 shares of the financial services provider’s stock after buying an additional 4,205 shares during the period. Kingswood Wealth Advisors LLC’s holdings in Aflac were worth $584,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in AFL. Eudaimonia Partners LLC lifted its stake in Aflac by 234.6% during the fourth quarter. Eudaimonia Partners LLC now owns 10,448 shares of the financial services provider’s stock worth $862,000 after purchasing an additional 7,325 shares during the last quarter. BKM Wealth Management LLC acquired a new position in shares of Aflac in the 4th quarter valued at about $1,558,000. Crossmark Global Holdings Inc. raised its stake in Aflac by 22.6% during the fourth quarter. Crossmark Global Holdings Inc. now owns 86,010 shares of the financial services provider’s stock worth $7,096,000 after acquiring an additional 15,855 shares during the period. Southeast Asset Advisors Inc. lifted its holdings in Aflac by 0.4% in the fourth quarter. Southeast Asset Advisors Inc. now owns 139,164 shares of the financial services provider’s stock worth $11,481,000 after acquiring an additional 589 shares during the last quarter. Finally, Richard C. Young & CO. LTD. acquired a new position in Aflac in the fourth quarter valued at approximately $12,546,000. Institutional investors and hedge funds own 67.44% of the company’s stock.

Insider Activity at Aflac

In other Aflac news, Director Charles D. Lake II sold 22,378 shares of the company’s stock in a transaction on Tuesday, May 21st. The stock was sold at an average price of $87.47, for a total value of $1,957,403.66. Following the transaction, the director now owns 61,522 shares of the company’s stock, valued at $5,381,329.34. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other Aflac news, Director Joseph L. Moskowitz sold 600 shares of the firm’s stock in a transaction dated Wednesday, May 8th. The shares were sold at an average price of $84.84, for a total value of $50,904.00. Following the completion of the transaction, the director now directly owns 27,550 shares in the company, valued at $2,337,342. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Charles D. Lake II sold 22,378 shares of the business’s stock in a transaction that occurred on Tuesday, May 21st. The shares were sold at an average price of $87.47, for a total transaction of $1,957,403.66. Following the sale, the director now owns 61,522 shares in the company, valued at approximately $5,381,329.34. The disclosure for this sale can be found here. Company insiders own 0.80% of the company’s stock.

Aflac Stock Performance

AFL opened at $89.18 on Thursday. Aflac Incorporated has a 1-year low of $67.12 and a 1-year high of $91.15. The company has a market capitalization of $50.67 billion, a price-to-earnings ratio of 9.84, a price-to-earnings-growth ratio of 2.22 and a beta of 0.96. The business has a 50 day moving average price of $86.57 and a two-hundred day moving average price of $83.71. The company has a debt-to-equity ratio of 0.34, a current ratio of 0.08 and a quick ratio of 0.08.

Aflac (NYSE:AFL) last announced its earnings results on Monday, May 6th. The financial services provider reported $1.66 earnings per share for the quarter, beating the consensus estimate of $1.58 by $0.08. Aflac had a return on equity of 16.88% and a net margin of 27.67%. The business had revenue of $5.44 billion during the quarter, compared to analysts’ expectations of $4.09 billion. During the same quarter last year, the business posted $1.55 earnings per share. The company’s quarterly revenue was up 13.3% on a year-over-year basis. Research analysts predict that Aflac Incorporated will post 6.46 EPS for the current fiscal year.

Aflac Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 3rd. Investors of record on Wednesday, May 22nd were issued a $0.50 dividend. This is an increase from Aflac’s previous quarterly dividend of $0.42. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.24%. The ex-dividend date of this dividend was Tuesday, May 21st. Aflac’s payout ratio is presently 22.08%.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the company. Wells Fargo & Company raised their price target on Aflac from $81.00 to $82.00 and gave the stock an “equal weight” rating in a report on Friday, May 10th. Morgan Stanley raised their target price on Aflac from $80.00 to $84.00 and gave the company an “equal weight” rating in a research note on Monday, April 15th. Keefe, Bruyette & Woods upped their price target on shares of Aflac from $83.00 to $87.00 and gave the stock a “market perform” rating in a research report on Wednesday, April 10th. Truist Financial lifted their price objective on shares of Aflac from $80.00 to $82.00 and gave the company a “hold” rating in a research report on Friday, May 3rd. Finally, StockNews.com upgraded shares of Aflac from a “sell” rating to a “hold” rating in a research report on Friday, May 3rd. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company. According to MarketBeat, Aflac has an average rating of “Hold” and an average target price of $82.38.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.